Ioannis Tarnanas | Nature Portfolio Health Community
Dr. Ioannis Tarnanas, Ph.D. - Founder - Altoida, Inc. | LinkedIn
Altoida, Inc. - Contacts, Employees, Board Members, Advisors & Alumni
Interview with Dr. Panagiotis Vlamos and Dr. Ioannis Tarnanas - IED
New Alzheimer's Prediction Smartphone App Gets FDA Breakthrough Status - Being Patient
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
2018 EIT Innovators Award Winner Ioannis Tarnanas | EIT
Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
New Alzheimer's Prediction Smartphone App Gets FDA Breakthrough Status - Being Patient
Dr. Ioannis Tarnanas, Ph.D. - Founder - Altoida, Inc. | LinkedIn
EIT Health - Ioannis Tarnanas is the winner of #EIT Innovators Award. He is CSO for Altoida- makers of ADPS, which can tell if someone will develop Alzheimer's disease within 6 years,
Ioannis Tarnanas - Worldwebforum
Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease
Cognitive Health & Digital Biomarker Technologies | Altoida
Greek Researcher Receives Top European Innovation Award (video)
Ioannis Tarnanas's email & phone | Altoida's Founder email
Cognitive Health & Digital Biomarker Technologies | Altoida
Altoida, Inc. - Contacts, Employees, Board Members, Advisors & Alumni
EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the
Ioannis Tarnanas - Worldwebforum
Altoida - Diagnosing Alzheimer's Disease 5 years prior to it's onset using Augmented Reality on your iPhone | Startup Ranking
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Ioannis Tarnanas - Worldwebforum
Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study | npj Digital Medicine
